Oral laxatives after hip fracture surgery: A randomised controlled trial

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2024-513871-42-00

Enrollment

375

Registered

2024-07-04

Start date

2024-10-01

Completion date

Unknown

Last updated

2025-07-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hip fracture

Brief summary

The proportion of patients in each group who needs recue medication after 72 hours or rescue medication before 72 hours on behalf of a medical assessment

Interventions

DRUGMACROGOL

DRUGCOMBINATIONS

DRUGBISACODYL

Eligibility

Sex/Gender

All

Age

65 Years to No maximum

Design outcomes

Primary

Measure	Time frame
The proportion of patients in each group who needs recue medication after 72 hours or rescue medication before 72 hours on behalf of a medical assessment	—

Countries

Denmark

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026